ONESOURCENSEOffline
ONESOURCE SPECIALTY · INE013P01021 · Small Cap · #382- Prev close
- 1,583.60
- Open
- —
- High
- —
- Low
- —
- Volume
- —
- Mkt cap (6-mo avg)
- ₹17,838 cr
Loading minute bars…
NSE 1-minute bars from our CandleApi gateway (history from 21 Jul 2026); longer timeframes are built from them. Prices not adjusted for corporate actions.
ONESOURCE is 16% below its 52-week high, above its 200-day average, ahead of Healthcare by 0.9 pts over 3 months — a Small Cap company, #382 by market cap.NSE prices to 05 Nov 2026 · a description of the data, not advice
Overview
What the data says, line by line
A description, never a buy or sell word · tap a line for its detail
How big is it?
six-month average market cap
Our own six-month average, computed the way AMFI computes it; the published classification is on the market cap page.
Did buyers take delivery?
latest session · 2026-11-05
Price & trend
Returns
to 05 Nov 2026
| Period | Stock | vs Nifty 500 | vs its industry |
|---|---|---|---|
| 1 week | +0.8% | −4.8 pts | — |
| 1 month | +3.0% | −1.5 pts | −0.9 pts |
| 3 months | +1.8% | +4.1 pts | +0.9 pts |
| 6 months | −9.3% | −9.6 pts | −18.2 pts |
| 1 year | −14.4% | −12.2 pts | — |
Industry: Healthcare (Nifty 500 classification) · rank 5 of 44 over 3 months. Points = the stock’s return minus the benchmark’s. Prices adjusted for splits and bonuses.
Averages & movement
Ownership
Who owns the company
% of all shares, by quarter
| Group | Dec 25 | Mar 26 | Jun 26 | Sep 26 |
|---|---|---|---|---|
| Promoters | 29.9% | 30.5% +0.6 | 30.5% | 30.5% |
| FPI | 19.2% | 17.5% −1.7 | 19.2% +1.7 | 19.4% +0.3 |
| Mutual funds | 9.0% | 10.1% +1.1 | 13.0% +2.8 | 13.8% +0.8 |
| Other DII | 9.6% | 10.5% +0.8 | 10.4% −0.1 | 10.4% |
| Individuals | 12.4% | 12.2% −0.2 | 11.3% −0.9 | 11.2% −0.1 |
| Others | 19.8% | 19.2% −0.5 | 15.7% −3.6 | 14.7% −1.0 |
From the company’s quarterly shareholding pattern. Changes in percentage points against the quarter before. No quarters are on record between Sep 2022 and Jun 2025.
Promoter pledge
Sep 26
Holders
Sep 26
Indian passive funds’ stake
2026-06-30
4,83,140 shares held by Indian passive mutual-fund schemes. A floor, not the total — foreign ETFs, insurance and EPFO are not counted.
Which funds bought and sold
mutual funds · quarter ended 2026-06-30
| Fund | Shares | Change | Did |
|---|---|---|---|
| WOC Pharma and Healthcare Fund-Reg(G)Active | +45,082 | +444.2% | bought |
| Motilal Oswal Flexi Cap Fund-Reg(G)Active | +16,90,955 | +272.6% | bought |
| Motilal Oswal Special Opportunities Fund-Reg(G)Active | +13,058 | +127.2% | bought |
| Mirae Asset Small Cap Fund-Reg(G)Active | −1,34,447 | −40.2% | sold |
| LIC MF Healthcare Fund-Reg(G)Active | −7,150 | −32.3% | sold |
| LIC MF Value Fund-Reg(G)Active | −7,235 | −28.9% | sold |
Ranked by how much each fund changed its own position, not by size of trade. Every fund here still holds the company — one that sold out entirely leaves no record to find.
Mutual-fund schemes, month by month
fund houses’ own monthly portfolios
| Month | Schemes | Bought new | Added | Cut | Sold out | Shares held | Value |
|---|---|---|---|---|---|---|---|
| Sep 26 | 80 | 5 | 14 | 29 | 3 | +1.6% | ₹2,216 cr |
| Aug 26 | 78 | 5 | 39 | 4 | 3 | −1.4% | ₹2,178 cr |
| Jul 26 | 76 | 6 | 43 | 13 | 6 | +5.0% | ₹2,355 cr |
| Jun 26 | 76 | 1 | 48 | 4 | 1 | +1.7% | ₹2,281 cr |
| May 26 | 76 | 2 | 28 | 18 | 1 | +6.2% | ₹2,483 cr |
| Apr 26 | 75 | 10 | 36 | 9 | 2 | +19.3% | ₹2,228 cr |
Each month against the one before, counting only the fund houses that reported both (45 houses in Sep 26); a split or bonus is divided out first. “Partial” = fewer than five houses reported yet.
Fund ownership is a quarterly disclosure and counts Indian passive schemes only.
Results
Results
Events & filings
Insider trades
SEBI PIT disclosures filed with NSE
| 04 Feb 2026 | TENSHI PHARMACEUTICALS PRIVATE LIMITED | Promoters | Buy | 85,000 | ₹1.02 cr | 18.40% | Market Purchase |
| 02 Feb 2026 | PRONOMZ VENTURES LLP | Promoter Group | Buy | 45,000 | ₹5.1 cr | 2.41% | Market Purchase |
| 02 Feb 2026 | TENSHI PHARMACEUTICALS PRIVATE LIMITED | Promoters | Buy | 2,05,000 | ₹23.88 cr | 18.33% | Market Purchase |
| 30 Jan 2026 | PRONOMZ VENTURES LLP | Promoter Group | Buy | 33,906 | ₹4.05 cr | 2.37% | Market Purchase |
| 30 Jan 2026 | Tenshi Pharmaceuticals Private Limited | Promoters | Buy | 75,000 | ₹8.71 cr | 18.15% | Market Purchase |
| 28 Jan 2026 | Tenshi Pharmaceuticals Private Limited | Promoters | Buy | 2,00,000 | ₹2.08 cr | 18.09% | Market Purchase |
| 13 Jun 2025 | Pronomz Ventures LLP | Promoter Group | Sell | 51,02,548 | ₹1,009 cr | 2.34% | Off Market |
| 06 Feb 2025 | Sajitha Pillai | Promoter Group | Sell | 5,000 | ₹0.77 cr | 0.03% | Market Sale |
| 05 Feb 2025 | Sajitha Pillai | Promoter Group | Sell | 7,500 | ₹1.15 cr | 0.03% | Market Sale |
| 03 Feb 2025 | Neeraj Sharma | Director | Sell | 20,000 | ₹2.97 cr | 0.12% | Market Sale |
| 03 Feb 2025 | Hemalatha Pillai | Promoter Group | Sell | 18,000 | ₹2.62 cr | 0.00% | Market Sale |
| 31 Jan 2025 | Hemalatha Pillai | Promoter Group | Sell | 12,000 | ₹1.9 cr | 0.02% | Market Sale |
| 31 Jan 2025 | Pronomz Ventures LLP | Promoter Group | Sell | 5,82,524 | ₹90 cr | 6.80% | Market Sale |
| 31 Jan 2025 | Vineetha Mohankumar Pillai | Promoter Group | Sell | 47,500 | ₹7.44 cr | 0.04% | Market Sale |
| 31 Jan 2025 | Padmakumar Karunakaran Pillai | Promoter Group | Sell | 50,000 | ₹7.79 cr | 0.04% | Market Sale |
Sums count buys and sells of equity (market and off-market); pledges are listed but not summed. From NSE’s filings: the archive to 2 May 2026, its XBRL filings since (NSE circular NSE/CML/2026/12). A filing describes what was done, not why.
Disclosures & deals
last six months · NSE filings
- Board outcome27 Oct 2026
- Credit rating18 Aug 2026
- Board outcome27 Jul 2026
ONESOURCE: only ratings, pledges, insider and takeover disclosures, buybacks, schemes, board outcomes and deals are listed. All deals.
Market capitalisation is our own six-month average, computed the way AMFI computes it; the published classification is on the market cap page. Fund ownership is a quarterly disclosure and counts Indian passive schemes only. Nothing here is advice, a recommendation, or a view on the company.